The Ki-67 indexes were significantly different between the WHO grade 2 and 3, 2 and 4, and 3 and 4 gliomas (U = 27, 3 and 11, respectively; P = 0.001, P < 0.001 and P < 0.001, respectively). This evidence concerns the gene MKI67 and central nervous system cancer.